CENTRE HOSPITALIER DE PAU
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1520-01-01
- Employees
- -
- Market Cap
- -
Intrathecal Rituximab in Progressive Multiple Sclerosis
Phase 2
Completed
- Conditions
- Multiple Sclerosis, Chronic ProgressiveNervous System Diseases
- Interventions
- First Posted Date
- 2015-09-10
- Last Posted Date
- 2019-10-03
- Lead Sponsor
- Centre Hospitalier de PAU
- Target Recruit Count
- 10
- Registration Number
- NCT02545959
- Locations
- 🇫🇷
Centre hospitalier F. Mitterrand (CH Pau), Pau, France
Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Phase 4
Terminated
- Conditions
- Coronary Artery Disease
- Interventions
- First Posted Date
- 2008-04-29
- Last Posted Date
- 2019-05-17
- Lead Sponsor
- Centre Hospitalier de PAU
- Target Recruit Count
- 99
- Registration Number
- NCT00669149
- Locations
- 🇫🇷
Centre Hospitalier de Pau, PAU, Pyrénées-Atlantiques, France
© Copyright 2025. All Rights Reserved by MedPath